全文获取类型
收费全文 | 15163篇 |
免费 | 1402篇 |
国内免费 | 66篇 |
专业分类
耳鼻咽喉 | 202篇 |
儿科学 | 352篇 |
妇产科学 | 225篇 |
基础医学 | 2013篇 |
口腔科学 | 223篇 |
临床医学 | 1529篇 |
内科学 | 3268篇 |
皮肤病学 | 379篇 |
神经病学 | 944篇 |
特种医学 | 610篇 |
外科学 | 2575篇 |
综合类 | 115篇 |
现状与发展 | 1篇 |
一般理论 | 4篇 |
预防医学 | 1273篇 |
眼科学 | 512篇 |
药学 | 1133篇 |
中国医学 | 90篇 |
肿瘤学 | 1183篇 |
出版年
2023年 | 153篇 |
2022年 | 124篇 |
2021年 | 696篇 |
2020年 | 455篇 |
2019年 | 561篇 |
2018年 | 650篇 |
2017年 | 431篇 |
2016年 | 510篇 |
2015年 | 526篇 |
2014年 | 659篇 |
2013年 | 714篇 |
2012年 | 1137篇 |
2011年 | 1098篇 |
2010年 | 654篇 |
2009年 | 529篇 |
2008年 | 911篇 |
2007年 | 895篇 |
2006年 | 756篇 |
2005年 | 705篇 |
2004年 | 623篇 |
2003年 | 548篇 |
2002年 | 498篇 |
2001年 | 497篇 |
2000年 | 455篇 |
1999年 | 369篇 |
1998年 | 109篇 |
1997年 | 87篇 |
1996年 | 82篇 |
1995年 | 77篇 |
1994年 | 66篇 |
1993年 | 60篇 |
1992年 | 151篇 |
1991年 | 105篇 |
1990年 | 118篇 |
1989年 | 108篇 |
1988年 | 94篇 |
1987年 | 79篇 |
1986年 | 65篇 |
1985年 | 59篇 |
1984年 | 50篇 |
1983年 | 32篇 |
1982年 | 19篇 |
1981年 | 12篇 |
1980年 | 14篇 |
1979年 | 16篇 |
1978年 | 7篇 |
1977年 | 13篇 |
1976年 | 9篇 |
1975年 | 7篇 |
1973年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 190 毫秒
1.
2.
3.
Trong N. Nguyen Anthony S. Podkowa Trevor H. Park Rita J. Miller Minh N. Do Michael L. Oelze 《Ultrasound in medicine & biology》2021,47(3):556-568
Quantitative ultrasound (QUS) was used to classify rabbits that were induced to have liver disease by placing them on a fatty diet for a defined duration and/or periodically injecting them with CCl4. The ground truth of the liver state was based on lipid liver percents estimated via the Folch assay and hydroxyproline concentration to quantify fibrosis. Rabbits were scanned ultrasonically in vivo using a SonixOne scanner and an L9-4/38 linear array. Liver fat percentage was classified based on the ultrasonic backscattered radiofrequency (RF) signals from the livers using either QUS or a 1-D convolutional neural network (CNN). Use of QUS parameters with linear regression and canonical correlation analysis demonstrated that the QUS parameters could differentiate between livers with lipid levels above or below 5%. However, the QUS parameters were not sensitive to fibrosis. The CNN was implemented by analyzing raw RF ultrasound signals without using separate reference data. The CNN outputs the classification of liver as either above or below a threshold of 5% fat level in the liver. The CNN outperformed the classification utilizing the QUS parameters combined with a support vector machine in differentiating between low and high lipid liver levels (i.e., accuracies of 74% versus 59% on the testing data). Therefore, although the CNN did not provide a physical interpretation of the tissue properties (e.g., attenuation of the medium or scatterer properties) the CNN had much higher accuracy in predicting fatty liver state and did not require an external reference scan. 相似文献
4.
5.
Syed S. Razi Joy A. Stephens-McDonnough Safi Haq Michael Fabbro Aliercy Nunez Sanchez Richard H. Epstein Nestor R. Villamizar Dao M. Nguyen 《The Journal of thoracic and cardiovascular surgery》2021,161(5):1689-1701
ObjectiveTo evaluate differences in postoperative pain control and opioids requirement in thoracic surgical patients following implementation of an Enhanced Recovery after Thoracic Surgery protocol with a comprehensive postoperative pain management strategy.Material and MethodsA retrospective analysis of a prospectively maintained database of patients undergoing pulmonary resections by robotic thoracoscopy or thoracotomy from January 1, 2017, to January 31, 2019, was conducted. Multimodal pain management strategy (opioid-sparing analgesics, infiltration of liposomal bupivacaine to intercostal spaces and surgical sites, and elimination of thoracic epidural analgesia use in thoracotomy patients) was implemented as part of Enhanced Recovery after Thoracic Surgery on February 1, 2018. Outcome metrics including patient-reported pain levels, in-hospital and postdischarge opioids use, postoperative complications, and length of stay were compared before and after protocol implementation.ResultsIn total, 310 robotic thoracoscopy and 62 thoracotomy patients met the inclusion criteria. This pain management strategy was associated with significant reduction of postoperative pain in both groups with an overall reduction of postoperative opioids requirement. Median in-hospital opioids use (morphine milligram equivalent per day) was reduced from 30 to 18.36 (P = .009) for the robotic thoracoscopy group and slightly increased from 15.48 to 21.0 (P = .27) in the thoracotomy group. More importantly, median postdischarge opioids prescribed (total morphine milligram equivalent) was significantly reduced from 480.0 to 150.0 (P < .001) and 887.5 to 150.0 (P < .001) for the thoracoscopy and thoracotomy groups, respectively. Similar short-term perioperative outcomes were observed in both groups before and following protocol implementation.ConclusionsImplementation of Enhanced Recovery after Thoracic Surgery allows safe elimination of epidural use, better pain control, and less postoperative opioids use, especially a drastic reduction of postdischarge opioid need, without adversely affecting outcomes. 相似文献
6.
Claire Périllaud Benoît Pilmis Julien Diep Gauthier Péan de Ponfilly Barbara Vidal Carine Couzigou Assaf Mizrahi Julie Lourtet-Hascoët Alban Le Monnier Jean-Claude Nguyen Van 《Diagnostic microbiology and infectious disease》2019,93(1):14-21
Background
With the worldwide spread of antibiotic resistance, delivering antibiotic susceptibility test (AST) results in a timely manner represents a major challenge. In cases of sepsis, rapid AST may facilitate early optimization of empiric antibiotic therapy. Disc diffusion is a well-standardized AST method, however 16 to 24?h are required to achieve an overall AST profile according to antimicrobial societies.Methods
In this prospective pilot study, we evaluated the performance of Mueller-Hinton-Rapid-SIR (MHR-SIR) agar after 6–8?h of incubation in comparison with standard MH agar after 16?h of incubation directly on positive blood cultures caused by Enterobacteriaceae and Staphylococcus aureus from routine clinical microbiology.A total of 133 positive blood samples including 110 Enterobacteriaceae (83%) and 23 Staphylococcus aureus (17%) were tested in parallel by two direct AST methods, each using EUCAST breakpoints. For each combination bacterium and antibiotic, we compared the categorical agreement and the correlation between the diameters obtained by MHR-SIR and by standard MH.Results
Our results showed 97.7% categorical agreement for Enterobacteriaceae, with 1.4% minor errors, 0.4% major errors and 0.5% very major errors. For S. aureus, we observed 97.8% categorical agreement, 1.9% minor errors, 0.3% major errors and no very major errors.Conclusion
Our results showed excellent categorical agreement and correlations between diameters for MHR-SIR and standard MH methods. MHRSIR can predict the result of overall AST profile within 6–8?h with reliable results. AST is obtained on the same day the blood culture becomes positive, with a very moderate cost. 相似文献7.
Martin T. King Paul L. Nguyen Ninjin Boldbaatar David D. Yang Vinayak Muralidhar Clare M. Tempany Robert A. Cormack Mark D. Hurwitz W. Warren Suh Mark M. Pomerantz Anthony V. DAmico Peter F. Orio 《Brachytherapy》2019,18(2):198-203
Purpose
Although current Delphi Consensus guidelines do not recommend a specific definition of biochemical recurrence after partial gland therapy, these guidelines acknowledge that serial prostate-specific antigen (PSA) tests remain the best marker for monitoring disease after treatment. The purpose of this study was to determine whether PSA velocity at failure per the Phoenix (nadir + 2 ng/mL) definition is associated with metastasis and prostate cancer-specific mortality (PCSM) in a cohort of patients who experienced PSA failure after partial gland therapy.Methods
Between 1997 and 2007, 285 patients with favorable risk prostate cancer underwent partial prostate brachytherapy to the peripheral zone. PSA velocity was calculated for 94 patients who experienced PSA failure per the Phoenix (nadir + 2) definition. Fine and Gray competing risks regression was performed to determine whether PSA velocity and other clinical factors were associated with metastasis and PCSM.Results
The median time to PSA failure was 4.2 years (interquartile range: 2.2, 7.9), and the median followup time after PSA failure was 6.5 years (3.5–9.7). Seventeen patients developed metastases, and five experienced PCSM. On multivariate analysis, PSA velocity ≥3.0 ng/mL/year (adjusted hazard ratio 5.97; [2.57, 13.90]; p < 0.001) and PSA nadir (adjusted hazard ratio 0.39; [0.24, 0.64]; p < 0.001) were significantly associated with metastasis. PSA velocity ≥3.0 ng/mL/year was also associated with PCSM (HR 15.3; [1.8, 128.0]; p = 0.012) on univariate analysis.Conclusions
Rapid PSA velocity at PSA failure after partial gland treatment may be prognostic for long-term outcomes. 相似文献8.
9.
10.
Nagaendran Kandiah Yee Fai Chan Christopher Chen Darwin Dasig Jacqueline Dominguez Seol-Heui Han Jianping Jia SangYun Kim Panita Limpawattana Li-Ling Ng Dinh Toan Nguyen Paulus Anam Ong Encarnita Raya-Ampil Nor'izzati Saedon Vorapun Senanarong Siti Setiati Harjot Singh Chuthamanee Suthisisang Tong Mai Trang Yuda Turana Narayanaswamy Venketasubramanian Fee Mann Yong Yong Chul Youn Ralf Ihl 《CNS Neuroscience & Therapeutics》2021,27(2):149-162
BackgroundMild cognitive impairment (MCI) is a neurocognitive state between normal cognitive aging and dementia, with evidence of neuropsychological changes but insufficient functional decline to warrant a diagnosis of dementia. Individuals with MCI are at increased risk for progression to dementia; and an appreciable proportion display neuropsychiatric symptoms (NPS), also a known risk factor for dementia. Cerebrovascular disease (CVD) is thought to be an underdiagnosed contributor to MCI/dementia. The Ginkgo biloba extract, EGb 761®, is increasingly being used for the symptomatic treatment of cognitive disorders with/without CVD, due to its known neuroprotective effects and cerebrovascular benefits.AimsTo present consensus opinion from the ASian Clinical Expert group on Neurocognitive Disorders (ASCEND) regarding the role of EGb 761® in MCI.Materials & MethodsThe ASCEND Group reconvened in September 2019 to present and critically assess the current evidence on the general management of MCI, including the efficacy and safety of EGb 761® as a treatment option.ResultsEGb 761® has demonstrated symptomatic improvement in at least four randomized trials, in terms of cognitive performance, memory, recall and recognition, attention and concentration, anxiety, and NPS. There is also evidence that EGb 761® may help delay progression from MCI to dementia in some individuals.DiscussionEGb 761® is currently recommended in multiple guidelines for the symptomatic treatment of MCI. Due to its beneficial effects on cerebrovascular blood flow, it is reasonable to expect that EGb 761® may benefit MCI patients with underlying CVD.ConclusionAs an expert group, we suggest it is clinically appropriate to incorporate EGb 761® as part of the multidomain intervention for MCI. 相似文献